Trials / Completed
CompletedNCT03466697
Role of Dopamine Transporter in Glucose Control
Role of Dopamine Transporter in Glucose Loading of Healthy Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Pusan National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Healthy subjects will be enrolled in this study. Each subject will be scanned twice with F18-FP-CIT PET which is commercially available. F18-FP-CIT reflects dopamine transporter availability of striatum. Before each PET scan, subject will be injected either glucose or normal saline. Therefore, PET scan will reflect the changes of dopamine transporter availability after the injection of glucose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Glucose injection/Normal saline injection | Before each PET scan, subject will be injected either glucose or normal saline. |
Timeline
- Start date
- 2018-03-14
- Primary completion
- 2021-12-20
- Completion
- 2021-12-20
- First posted
- 2018-03-15
- Last updated
- 2022-04-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03466697. Inclusion in this directory is not an endorsement.